AC Immune SA
ACIU
Get informed when a big investor buys or sells
+ FollowMarket Cap$269.7M
Close$
$-0.08
102.8% downside
Current Fair Value
102.8% downsideOvervalued by 102.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $269.70 Million |
|---|---|
| Enterprise Value | $336.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.7 |
| Beta | 1.57 |
| Outstanding Shares | 98,673,333 |
Return
| Return on Equity | -122.41% |
|---|---|
| Return on Assets | -28.62% |
| Return on Invested Capital | -85.46% |
Valuation & Multiples
| P/E Ratio | -4.97 |
|---|---|
| PEG | 4.57 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 19.41 |
| Enterprise Value to EBIT | -7.86 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 2.7 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$9.59 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$247,252
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.2030▲ 210.30% |
|---|---|
| Total Calls | 47,300▼ 86.75% |
| Total Puts | 104,200▲ 191.88% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 24.80%▼ 0.62% |
|---|---|
| Total Invested | $58.24M▼ 15.55% |
| Investors Holding | 47▼ 4.00% |
ESG Score
No data
About AC Immune SA
CEO: Andrea Pfeifer